We are delighted that you have decided to visit our department’s website. Our mission also includes the education and mentoring of future researchers, physicians and physician-scientists and service to the AU and greater scientific community.
The research mission is focused on inventing better diagnostics and newer targeted therapies for the benign and malignant diseases of the bladder, brain, breast, eye, gastrointestinal tract, kidney, liver, and prostate. The research areas encompass biomarkers, chemoprevention, DNA damage and repair, drug resistance, the epigenome, immunotherapy, the microbiome, molecular signaling, natural products, protein modifications and targeted therapy. Our faculties are supported by major funding agencies, and the insight gained by their work has been published in reputable peer-reviewed journals.
Home to the Biochemistry and Cancer Biology Graduate Program, the BMB Department offers PhD degrees, along with a combined MD-PhD program available to medical students. The students move on to competitive careers in academia, industry, and governmental agencies. The education mission is also served by faculty participation in undergraduate and graduate medical education, as well as the Student Educational Enrichment Program (SEEP).
Working together as a cohesive academic family, the faculty, staff, students and fellows are committed to advancing BMB’s tripartite mission.
Department of Biochemistry and Molecular Biology
Health Sciences Campus
706-721-3271
Cancer Research Center, CN-1166
706-721-6608
Peter C. Harris, PhD
CN 1209 Knox Foundation Room
Weiqin Chen, PhD
CN 1209 Knox Foundation Room
David Mattson, PhD
CN 1209 Knox Foundation Room
While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found that sophisticated new subtyping techniques designed to do this provide no better information than long-standing pathology tests.
A transcription factor that aids neuron function also appears to enable a cell conversion in the prostate gland that can make an already recurrent cancer even more deadly, scientists say.
An enzyme induced by stress to help reduce production of damaging free radicals is also used by liver cancer to regulate two major cell proliferation pathways that enable the cancer to thrive, scientists report.
MCG scientists looking at body's natural checkpoint, the enzyme CD73, and how it may convert the cell fuel that normally promotes our immune system to attack head and neck cancer cells into something that instead inhibits that attack.
